Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...

The French drugmaker said it had entered a mandate with an “investment service provider”, with the purchase occurring between ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

Government faces healthcare crisis as new physician output drops significantly in Korea New challenges arise as disruptions in medical education threaten Koreas healthcare future.

One Zelienople child survived a serious health scare after coming down with respiratory syncytial virus in late January. The ...

A vaccine designed to help protect babies from the respiratory syncytial virus (RSV) is now free during pregnancy. RSV is the ...

L'Oréal is selling nearly 30 million shares in Sanofi, decreasing its stake in the drugmaker from 9.4% to 7.2%.

Sanofi’s fiscal year 2024 results were in line with expectations, with a noteworthy performance in their Vaccines division, particularly driven by Beyfortus. This offset a slight ...

Innovation was a key driver of our growth as launches already contributed 11% of sales, with Beyfortus becoming a blockbuster in its first full year of sales. “As we enter 2025, we expect continued, ...

This included Beyfortus that achieved blockbuster status ... we have a competitive profile with nirsevimab. We have an extensive amount of real-world evidence. You've seen many countries showing ...

We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, ...